Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The mechanism behind oral efficacy is attributed to systemic absorption and downstream peptide signaling rather than localized delivery, though the exact bioavailability percentage in humans remains unquantified
GLOW CAPSULES BPC-157 Arginate 500mcg + TB-500 (AC-SDKP) 500mcg + GHK-Cu 1mg Chemical Information BPC-157 Arginate : Pentadecapeptide (GEPPPGKPADDAGLV, arginate salt form) TB-500 (AC-SDKP) : Thymosin Beta-4 fragment (Ac-Ser-Asp-Lys-Pro) GHK-Cu : Glycyl-L-histidyl-L-lysine Copper Complex Total Active per Capsule : 500mcg BPC-157 Arginate + 500mcg TB-500 (AC-SDKP) + 1mg GHK-Cu Product Description GLOW Capsules contain a research-grade synergistic blend of three bioactive peptides supplied as lyophilized powder in capsule form
It means the evidence is not yet strong enough to make definitive claims
Patients were randomized into three different treatment arms for 48 hours: Bolus group (bl) = furosemide 80 mg IV boluses, twice daily Continuous group (cIv) = IV furosemide 160 mg/day, given as a continuous infusion over 16 hours Hyperdiuresis group (HSS) = 160 mg IV furosemide plus 150 ml of 2% NaCl, twice daily infused over 30 minutes Patients in the hyperdiuresis group had shorter hospital length of stay (table below)
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
